The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs

The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs

Purpose This study assessed the presentation and institutional outcomes treating brain metastases (BM) of breast cancer (BC), non-small cell lung cancer (NSCLC), and melanoma origin. Methods Patients with brain metastases treated between 2014 and 2019 with primary melanoma, NSCLC, and BC were identi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research and treatment 2022, Vol.191 (1), p.209-217
Hauptverfasser: Mills, Matthew N., Potluri, Thrisha K., Kawahara, Yuki, Fahey, Matthew, Figura, Nicholas B., Soyano, Aixa E., Washington, Iman R., Diaz, Roberto, Oliver, Daniel E., Yu, Hsiang-Hsuan Michael, Etame, Arnold B., Vogelbaum, Michael A., Czerniecki, Brian J., Arrington, John A., Sahebjam, Solmaz, Forsyth, Peter A., Soliman, Hatem H., Han, Hyo S., Ahmed, Kamran A.
Format: Artikel
Sprache:eng
Schlagworte:
Brain
Brain cancer
Brain Neoplasms - diagnostic imaging
Brain Neoplasms - epidemiology
Breast cancer
Breast Neoplasms - diagnostic imaging
Breast Neoplasms - epidemiology
Brief Communication
Cancer
Cancer research
Carcinoma, Non-Small-Cell Lung - diagnostic imaging
Carcinoma, Non-Small-Cell Lung - epidemiology
Diagnosis
Early Detection of Cancer
Female
Humans
Lung cancer
Lung cancer, Non-small cell
Lung cancer, Small cell
Lung Neoplasms - diagnostic imaging
Magnetic Resonance Imaging
Medicine
Medicine & Public Health
Melanoma
Melanoma - diagnostic imaging
Meninges
Metastases
Metastasis
Middle Aged
Non-small cell lung carcinoma
Oncology
Oncology, Experimental
Patients
Radiation therapy
Radiotherapy
Retrospective Studies
Small cell lung carcinoma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose This study assessed the presentation and institutional outcomes treating brain metastases (BM) of breast cancer (BC), non-small cell lung cancer (NSCLC), and melanoma origin. Methods Patients with brain metastases treated between 2014 and 2019 with primary melanoma, NSCLC, and BC were identified. Overall survival (OS) was calculated from dates of initial BM diagnosis using the Kaplan–Meier method. Results A total of 959 patients were identified including melanoma (31%), NSCLC (51%), and BC (18%). Patients with BC were younger at BM diagnosis (median age: 57) than NSCLC (65) and melanoma patients (62, p  
ISSN:0167-6806
1573-7217
DOI:10.1007/s10549-021-06420-3